HOLX

Bearish

Needles used to detect breast cancer in shortage from recall

The U.S. is facing a shortage of breast biopsy needles due to a recall by Hologic Inc. earlier this year, which could delay breast cancer diagnoses. T...

Fortune 1 week ago 0

Bullish

Hologic wins patent case against Siemens Healthineers over mammo technology

Hologic has won a patent infringement case against Siemens Healthineers concerning breast tomosynthesis imaging technology. The Unified Patent Court’s...

DOTmed 1 week ago 0

Bullish

Hologic’s New Sustainability Report Marks 40 Years of Impact

Hologic has released a new sustainability report, coinciding with the company's 40th anniversary. This report highlights Hologic's long-standing impac...

PA Media 1 week ago 0

Bullish

Hologic’s New Sustainability Report Marks 40 Years of Impact

Hologic, Inc. has released its 2025 Sustainability Report, coinciding with the company's 40th anniversary. The report highlights progress in reducing ...

Business Wire 1 week ago 0

Bullish

Hologic Secures Significant Patent Victory Against Siemens Over Breast Cancer Detection Technology

Hologic has achieved a significant patent victory against Siemens concerning breast cancer detection technology. This news, reported by Refinitiv via ...

TradingView 1 week ago 0

Neutral

Hologic Inc Stock (US4364401012): S&P 500 exit keeps women’s health specialist on U.S. investors

Hologic Inc. remains a key focus for U.S. investors despite its exit from the S&P 500, trading on the Nasdaq under HOLX. The removal prompted discussi...

AD HOC NEWS 1 week ago 0